Skip to main content
PLSM
NASDAQ Industrial Applications And Services

Pulsenmore Launches At-Home Fertility Monitoring Service with Clalit Health Services, Securing $4.5M Deal

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$6.36
Mkt Cap
$38.497M
52W Low
$5.81
52W High
$10.28
Market data snapshot near publication time

Summary

Pulsenmore Ltd. announced a strategic commercial agreement with Clalit Health Services, Israel's largest HMO, to launch its Pulsenmore FC at-home follicular monitoring service, potentially valued at $4.5 million over five years.


Key Events

  • Feasibility Trial Success Confirmed

    Clalit Health Services confirmed that the feasibility trial for Pulsenmore FC met the study protocol criteria, paving the way for commercialization.

  • New Commercial Agreement Signed

    Pulsenmore and Clalit entered into an 18-month pilot period, followed by a five-year commercial term for the Pulsenmore FC system, an increase from the previous four-year term.

  • Significant Revenue Potential

    The agreement is potentially valued at approximately $4.5 million over five years following the pilot, with a minimum annual purchase commitment of 2,000 Pulsenmore FC units.

  • Innovative At-Home Fertility Monitoring

    The service will be deployed via Beilinson NEXT, Rabin Medical Center's virtual hospital platform, enabling patients to perform follicular monitoring scans from home with clinical oversight.


Analysis

This filing announces a significant commercial agreement for Pulsenmore's at-home follicular monitoring system (Pulsenmore FC) with Clalit Health Services, Israel's largest HMO. The agreement, potentially valued at $4.5 million over five years, follows the successful completion of a feasibility trial, which was a condition of the initial 2021 agreement. This represents a substantial revenue stream for Pulsenmore relative to its market capitalization and validates its technology for a critical application in fertility care. The partnership expands Pulsenmore's existing relationship with Clalit and establishes an innovative care model through a virtual hospital platform, enhancing patient access and convenience for IVF and fertility preservation.

At the time of this filing, PLSM was trading at $6.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $38.5M. The 52-week trading range was $5.81 to $10.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PLSM - Latest Insights

PLSM
Jun 12, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.03
Real-time Price: $4.03 info
Change: $0 (0%) info
Market Cap: $26.174M info
PLSM
May 07, 2026, 4:49 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.59
Real-time Price: $4.03 info
Change: +$0.435 (+12%) info
Market Cap: $26.174M info
PLSM
Mar 30, 2026, 8:38 AM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $3.60
Real-time Price: $4.03 info
Change: +$0.425 (+12%) info
Market Cap: $26.174M info
PLSM
Feb 09, 2026, 7:05 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.90
Real-time Price: $4.03 info
Change: -$1.88 (-32%) info
Market Cap: $26.174M info
PLSM
Feb 02, 2026, 7:35 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $4.03 info
Change: -$2.07 (-34%) info
Market Cap: $26.174M info
PLSM
Jan 27, 2026, 1:15 PM EST
Filing Type: SEC STAFF ACTION
Importance Score:
7
Price at Filing: $6.20
Real-time Price: $4.03 info
Change: -$2.18 (-35%) info
Market Cap: $26.174M info
PLSM
Jan 26, 2026, 8:05 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.36
Real-time Price: $4.03 info
Change: -$2.34 (-37%) info
Market Cap: $26.174M info